Clinical Trial Update: Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of AEF0217 in Down syndrome has completed, according to the sponsor Aelis Farma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• AEF0217

Snippet

Sponsor: Aelis Farma | Conditions: Down Syndrome | Phase 1, Phase 2 | Status: COMPLETED